» Articles » PMID: 9282244

Vitamin D: an Antiproliferative Agent with Potential for Therapy of Squamous Cell Carcinoma

Overview
Date 1997 Sep 1
PMID 9282244
Citations 6
Authors
Affiliations
Soon will be listed here.
Citing Articles

Epigenetic regulation of vitamin D metabolism in human lung adenocarcinoma.

Ramnath N, Nadal E, Jeon C, Sandoval J, Colacino J, Rozek L J Thorac Oncol. 2014; 9(4):473-82.

PMID: 24736069 PMC: 3994461. DOI: 10.1097/JTO.0000000000000114.


Regulation of motility, invasion, and metastatic potential of squamous cell carcinoma by 1α,25-dihydroxycholecalciferol.

Ma Y, Yu W, Su B, Seshadri M, Luo W, Trump D Cancer. 2012; 119(3):563-74.

PMID: 22833444 PMC: 3485450. DOI: 10.1002/cncr.27531.


CYP24A1 is an independent prognostic marker of survival in patients with lung adenocarcinoma.

Chen G, Kim S, King A, Zhao L, Simpson R, Christensen P Clin Cancer Res. 2010; 17(4):817-26.

PMID: 21169243 PMC: 3058389. DOI: 10.1158/1078-0432.CCR-10-1789.


Vitamin D in combination cancer treatment.

Ma Y, Trump D, Johnson C J Cancer. 2010; 1:101-7.

PMID: 20842231 PMC: 2938072. DOI: 10.7150/jca.1.101.


1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model.

Ma Y, Yu W, Hershberger P, Flynn G, Kong R, Trump D Mol Cancer Ther. 2008; 7(9):3047-55.

PMID: 18790784 PMC: 2587026. DOI: 10.1158/1535-7163.MCT-08-0243.